This offering is exclusively for use by non-commercial organizations.
The Institute for Health Metrics and Evaluation (IHME) at the University of Washington is regularly updating data on the current and projected spread of coronavirus disease 2019 (COVID-19), and on related on hospital resource needs versus capacity. The projections are designed to assist all those wishing to track the progression of this disease in the USA; the analysis is designed especially to help decision-makers prepare for and respond to a surge in cases and deaths by projecting, in addition to daily death counts, peak needs against peak capacity for, bed use, ICU use, and ventilator use. As the spread of the virus is rapidly changing, we are gathering new data, updating our models and producing new projections daily for as many locations as possible. This listing contains COVID-19 US state projections.
Data sets:
Data Sets contain findings generated by IHME’s COVID-19 analytic work. All data within the Data Sets will be population-level and no individual or identifiable health information will be included. This study used data on confirmed COVID-19 deaths by day from the World Health Organization (WHO) and local and national governments, data on hospital capacity and utilization for US states, and observed COVID-19 utilization data from select locations to develop a statistical model forecasting deaths and hospital utilization against capacity by state for the US over a future 4-month period.
A new revision will be published regularly, these revisions are not guaranteed to have updated data.
Commercial organizations wishing to acquire a license to access and download IHME data, including IHME's COVID-19 projections, should contact services@healthdata.org. IHME data available for use by commercial organizations through a license.
The Global Burden of Disease (GBD) study produces comprehensive and comparable estimates of health conditions around the globe, estimates that are informing real-world policy and implementation. Condition-specific data available for 195 country locations and a further 700 subnational units, including all the states of the US. The full list of GBD locations and conditions available from IHME Client Services.https://docs.google.com/spreadsheets/d/1X0ZnrPnEzrf3wJhMUo1--usXAokEjCmgQwAqxeOXYyk/edit?usp=sharing
AWS Marketplace now accepts line of credit payments through the PNC Vendor Finance program. This program is available to select AWS customers in the US, excluding NV, NC, ND, TN, & VT.
This listing offers one pricing option: Product Access, measured in units. It is free to subscribe. The single dimension grants you access to the product for non-commercial use. There are no tiers, instance sizes, or usage add-ons to choose between. You subscribe once to gain access, with no charges tied to volume or duration. The data covers COVID-19 US state-by-state projections.
Top-of-mind questions for buyers
What does one unit of Product Access grant me?
One unit grants you subscriber access to the COVID-19 US state-by-state projection dataset. It is a single access grant, not a per-user or per-record count. You subscribe once to reach the data. There are no volume-based or usage-based charges tied to this unit.
Does my cost change as I download more data or use it longer?
No. This listing is free, with a single access dimension. Your cost stays the same regardless of how much data you download or how long you keep your subscription. No usage thresholds, duration meters, or overage charges apply. Access is granted for non-commercial use.
What use is permitted, and what falls outside this free access?
This listing grants access for non-commercial use only. Applying the data to business needs requires a separate commercial licensing arrangement handled directly by the vendor, which is not part of this free subscription. Contact the vendor for commercial use details.
www.ihmeclientservices.org
Helpful?
Vendor refund policy
Refunds are not applicable to this product. For any questions, please contact services@healthdata.org.
How can we make this page better?
Tell us how we can improve this page, or report an issue with this product.
Give us feedbackReport a problem with this product or seller
Legal
Vendor terms and conditions
Upon subscribing to this product, you must acknowledge and agree to the terms and conditions outlined in the vendor's End User License Agreement (EULA).
Content disclaimer
Vendors are responsible for their product descriptions and other product content. AWS does not warrant that vendors' product descriptions or other product content are accurate, complete, reliable, current, or error-free.
This listing contains COVID-19 projections for countries in the European Economic Area (EEA). Projections are at the subnational level for three locations in the EEA: Germany, Italy and Spain.
Advanced Air Mobility Market Size, Trends and Insights By Component (Hardware, Software), By Type (Air Taxis, Drones, Others), By Propulsion Type (Gasoline, Electric, Hybrid), By Application (Cargo Transport, Passenger Transport, Mapping & Surveying, Special Mission, Surveillance & Monitoring, Others), By End User (Commercial, Government & Military), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025 - 2034
5G is the next generation of wireless network technology, after 4G. It offers much higher data rates, lower latency (less delay), and more capacity to handle more connected devices. It does this by using higher frequencies and better antenna technology, which makes new things possible like self-driving cars, faster mobile broadband, huge IoT connections, and real-time remote services.
ZEDOC's COVID-19 Digital Care Pathway is an end-to-end solution for remote monitoring of individuals with suspected for confirmed COVID-19. Automating the collection and analysis of COVID-19 symptoms, the pathway alerts clinical teams of deterioration as it happens.
ZEDOC's COVID-19 Digital Care Pathway is an end-to-end solution for remote monitoring of individuals with suspected for confirmed COVID-19. Automating the collection and analysis of COVID-19 symptoms, the pathway alerts clinical teams of deterioration as it happens.